Reta dose build-up and titration approaches

I did 2 mg for four weeks, then 5 mg for four weeks, then 6 mg for four weeks. The next step would have been 9 mg and possibly 12 mg later. I actually stayed at 6 mg for six or seven weeks until the scale stopped moving and the medication effects seemed to fade. Moved to 8 mg and have remained there. I’ve dropped 48 lb since January. Good luck.

Check out a glp plotter tool; it graphs how the drug concentration rises and falls with repeated weekly doses. The slow titration exists mainly to limit sudden strong side effects, since roughly one percent of users end up in hospital from dehydration caused by nausea and vomiting. After an injection it peaks in the blood around 24 hours later, which is usually when sides are worst, then halves about six days later. Because each new dose adds to what is already circulating, it takes roughly four weeks of weekly shots to reach the new plateau, so side effects can still intensify weeks after you raised the dose. That is why the standard advice is to wait four weeks before increasing again.

The phase-three trials began with 2 mg weekly for four weeks, then 4 mg for four weeks, 6 mg for four weeks, 9 mg for four weeks, and finally 12 mg for four weeks. The idea is to start at 2 mg and step up only as needed. Stay on the smallest amount that still works; if weight loss stops, then increase. I plateaued at 9 mg for two weeks after already being on it for six weeks total, moved to 12 mg, saw movement again for two weeks, and have now reached goal and am holding at 2 mg weekly.

I simplified the schedule a little because the bigger jumps from 6 mg straight to 9 mg and then to 12 mg seem more likely to trigger problems than smaller steps like 6, 8, 10, 12. Still, the four-week trial protocol you mentioned is the officially studied one.

I began at 0.25 mg and added 0.25 mg each week until I reached 4 mg. It took quite a while and results were modest, so I added 0.5 mg of Cagri to quiet the remaining hunger. That combination works for me. Different people get different outcomes.

Many cautious users begin at 1 mg or lower and raise the dose gradually to keep side effects from disrupting daily life. Quite a few also start seeing weight loss at those lower amounts. Bodies simply respond differently.

The medication accumulates over time. Once you are getting the results you want there is no advantage to raising the dose further.

Two main schools of thought exist. One tries to reach the highest dose quickly to finish the weight-loss phase fast and then move to maintenance. The largest losses, up to 30 percent of starting weight, come from staying at the top dose. The other approach looks for the lowest effective dose; one study showed 1 mg weekly for a year produced a 9 percent loss. I started tirz in December, added 2 mg reta in March after stalling at 1.66 mg tirz, and am titrating the reta upward over a month. Research protocols tend to favor the fast high-dose route while real-world use is more about experimenting to see what works for the individual.

Everyone responds differently. I began at 1 mg and never increased, lost 30 lb in eight weeks. Took a month off, restarted at 1 mg, and four weeks later am down another 10 lb. As long as weight is still coming off, stay at the lower dose.

Start low and move up slowly. The goal is not the highest possible dose but the dose that works for you. After six years on liraglutide I switched to reta eleven weeks ago and began at 2 mg, spent most of the time at 3 mg, and only went to 3.5 mg today. Down 10 kg so far while also recomping and training. Early weeks are mainly loading the system; by week three you should notice something. Suggested slow schedule from zero: 0.5 mg, then 1 mg, then 1 mg, then 1.5 mg if needed. Wait between increases and find the level where appetite control appears without troublesome sides.

Three basic rules apply when using experimental compounds without medical oversight: begin with two or three very small test doses to check tolerance and product quality; raise the dose only every four half-lives so you reach steady state and can judge the true effects; and never introduce multiple new compounds at once. Published trial doses are shaped by what the lab can supply, how easily patients can follow the schedule, and how researchers want to present the data. At this stage of knowledge, few firm rules exist beyond those principles.

I settled on a main dose every Sunday. After some weeks I added a 0.5 mg top-up on Thursday to handle weekend hunger. My full schedule from the start: week 1–2 at 2 mg, week 3 at 2.5 mg, week 4 at 3 mg, week 5 at 3.5 mg, then lowered to 3.2 mg and 3 mg because it felt like too much. Later weeks include the extra 0.5 mg mid-week when needed. Week 11 is another step up to 3.5 mg and I will see if the extra dose is still required.

Because of the half-life, blood levels rise over a month until they are nearly double the amount injected in the first week. That is why you should keep any new dose for at least a month before deciding to change it; otherwise you can overshoot by up to twofold. The body also needs time to adjust, and sides are worse with fast rises. The trial schedule that stepped up every four weeks is already aggressive; many people do fine on lower amounts if they judge by actual weight loss and appetite control rather than chasing a target dose.